Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Alkeran
Active Ingredient: Melphalan 2mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer: Glaxo Wellcome Operations, Temple Hill, Dartford, Kent, United Kingdom
Product: Ospexin
Active Ingredient: Cephalexin (monohydrate) 262.9mg equivalent to 250mg of cephalexin
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Biochemie GmbH, Kundl, Austria
Product: Ospexin
Active Ingredient: Cephalexin (monohydrate) 525.8mg equivalent to to 500mg cephalexin
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Biochemie GmbH, Kundl, Austria
Dated this 13th day of February 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).